Coelho Rogerio Vivaldi, Director at Crinetics Pharmaceuticals, Inc. (CRNX), sold 3,000 shares at $40.00 ($120K) on 2026-07-02, disclosed to the SEC on 2026-07-07.
Scheduled sale ($120k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ONCE | SELL | 2016-07-19 | $371K | — | Filing → |
| ONCE | SELL | 2016-04-22 | $280K | — | Filing → |
| ONCE | SELL | 2015-10-14 | $1.2M | — | Filing → |